PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2103
https://www.valueinhealthjournal.com/article/S1098-3015(12)03817-X/fulltext
Section Title :
Cancer
Section Order :
757
First Page :
A420
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03817-X&doi=10.1016/j.jval.2012.08.2103